In a murine model of non-alcoholic steatohepatitis, fibrosis was not reversed by IL-1Ra treatment, indicating that other regulators of NLRP3 inflammasome are involved in fibrogenesis promotion (33). Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.